 |
|
Recent advances in the management of hepatocellular carcinoma
Kamya Sankar, Jun Gong, Arsen Osipov, Steven A. Miles, Kambiz Kosari, Nicholas N. Nissen, Andrew E. Hendifar, Ekaterina K. Koltsova, Ju Dong Yang
Clin Mol Hepatol. 2024;30(1):1-15. Published online 2023 Jul 21 DOI: https://doi.org/10.3350/cmh.2023.0125
|
|
Citations to this article as recorded by
 The Critical Role of Regulatory T Cells in Immune Tolerance and Rejection Following Liver Transplantation: Interactions With the Gut Microbiome
Soon Kyu Lee, Jung Hyun Kwon, Jeong Won Jang, Si Hyun Bae, Seung Kew Yoon, Eun Sun Jung, Jong Young Choi
Transplantation.2025; 109(5): 784. CrossRef Artemyriantholidimers A-G, undescribed guaiane-type sesquiterpenoid dimers from Artemisia myriantha and their antihepatoma activities
Meng-Fei Wang, Tian-Ze Li, Yun-Bao Ma, Yong-Cui Wang, Qi-Hao Li, Feng-Jiao Li, Ji-Jun Chen
Phytochemistry.2025; 233: 114409. CrossRef The multifaceted roles of macrophages in the transition from hepatitis to hepatocellular carcinoma: From mechanisms to therapeutic strategies
Shuairan Zhang, Hang Dong, Xiuli Jin, Jing Sun, Yiling Li
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2025; 1871(3): 167676. CrossRef Organoids and spheroids: advanced in vitro models for liver cancer research
Mirella Pastore, Alessia Giachi, Elena Spínola-Lasso, Fabio Marra, Chiara Raggi
Frontiers in Cell and Developmental Biology.2025;[Epub] CrossRef Correspondence to editorial 2 on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: insights from the IMbrave150 trial”
Sun Young Yim, Sung Hwan Lee, Ji Hoon Kim, Sunyoung S Lee, Ahmed O Kaseb, Ju-Seog Lee
Clinical and Molecular Hepatology.2025; 31(1): e84. CrossRef Correspondence to editorial on “UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL”
Renyu Zhang, Ding Wei, Zhinan Chen, Huijie Bian
Clinical and Molecular Hepatology.2025; 31(1): e58. CrossRef Artificial intelligence-assisted platform performs high detection ability of hepatocellular carcinoma in CT images: an external clinical validation study
Rongxue Shan, Chenhao Pei, Qianrui Fan, Junchuan Liu, Dawei Wang, Shifeng Yang, Ximing Wang
BMC Cancer.2025;[Epub] CrossRef Correspondence to letter to the editor on “Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis”
Moon Haeng Hur, Yoon Jun Kim
Clinical and Molecular Hepatology.2025; 31(1): e93. CrossRef SERPINH1 secretion by cancer-associated fibroblasts promotes hepatocellular carcinoma malignancy through SENP3-mediated SP1/SQLE pathway
Hua Xiao, Zhaoying Yao, Tao Li, Xin Fang, Xuejiao Xu, Sheng Hu, Ya Yang, Chenchen Jin, Yuxiang Fei, Chao Liu, Qianming Du
International Immunopharmacology.2025; 150: 114259. CrossRef Celecoxib as a potential treatment for hepatocellular carcinoma in populations exposed to high PFAS levels
Boshi Sun, Yuqiao Zhao, Shifeng Yang, Xiaodong Li, Nana Li, Yujie Wang, Qixiang Han, Xuyun Liu, Qiushi Tu, Jie Zheng, Xinyu Zhang
Journal of Hazardous Materials.2025; 489: 137613. CrossRef Effect of Narrow-Margin Hepatectomy Combined with Intraoperative Radiotherapy on Long-Term Prognosis of Patients with Centrally Located Hepatocellular Carcinoma: A Propensity Score Matching Analysis
Changcheng Tao, Liguo Liu, Nan Hu, Hongwei Wang, Kai Zhang, Yue Liu, Fan Wu, Liming Wang, Weiqi Rong, Jianxiong Wu
Journal of Hepatocellular Carcinoma.2025; Volume 12: 261. CrossRef Exosome biosensors for detection of liver cancer
Asma Vafadar, Mohammad Younesi, Sepideh Babadi, Mehdi Alizadeh, Ahmad Movahedpour, Amir Savardashtaki
Clinica Chimica Acta.2025; 570: 120199. CrossRef Immunotherapy and liver transplantation for hepatocellular carcinoma: Current and future challenges
Theodoros Pettas, Sofia Lachanoudi, Filippos F Karageorgos, Ioannis A Ziogas, Asimina Fylaktou, Vassilios Papalois, Georgios Katsanos, Nikolaos Antoniadis, Georgios Tsoulfas
World Journal of Transplantation.2025;[Epub] CrossRef Management strategies for advanced hepatocellular carcinoma with
portal vein tumor thrombosis
Jeayeon Park, Su Jong Yu
The Ewha Medical Journal.2025;[Epub] CrossRef Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Soo Young Hwang, Pojsakorn Danpanichkul, Vatche Agopian, Neil Mehta, Neehar D. Parikh, Ghassan K. Abou-Alfa, Amit G. Singal, Ju Dong Yang
Clinical and Molecular Hepatology.2025; 31(Suppl): S228. CrossRef Evolving Transplant Oncology: Evolving Criteria for Better Decision-Making
Filippos F. Karageorgos, Konstantina-Eleni Karakasi, Athanasios Kofinas, Nikolaos Antoniadis, Georgios Katsanos, Georgios Tsoulfas
Diagnostics.2025; 15(7): 820. CrossRef Case Report: Posterior reversible encephalopathy syndrome after lenvatinib treatment for hepatocellular carcinoma
Minchun Chen, Jing Shen, Rongrong Jia, Mingze Chang, Jingyi Zhang, Jie Zheng, Runqing Xue, Lulu Guo, Kangkang Yan
Frontiers in Pharmacology.2025;[Epub] CrossRef Prognostic value of neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma receiving curative therapies: a systematic review and meta-analysis
Jinxiang Peng, Haozhu Chen, Zhuang Chen, Jinmei Tan, Feng Wu, Xiaojuan Li
BMC Cancer.2025;[Epub] CrossRef Management of hepatocellular carcinoma in elderly and adolescent/young adult populations
Han Ah Lee
Journal of Liver Cancer.2025; 25(1): 52. CrossRef Statistical Cure After Hepatectomy for Hepatitis B Virus-Associated Hepatocellular Carcinoma: A Risk-Stratification Model
Yi-Fan Li, Lan-Qing Yao, Chao Li, Hong Ren, Jin-Bo Gong, Han Wu, Li-Hui Gu, Ying-Jian Liang, Yu-Ze Yang, Kong-Ying Lin, Zi-Qiang Li, Qi-Xuan Zheng, Ting-Hao Chen, Ya-Hao Zhou, Hong Wang, Hong-Wei Guo, Jia-Hao Xu, Zhong Chen, Feng Shen, Ming-Da Wang, Tian
Annals of Surgical Oncology.2025; 32(6): 4396. CrossRef Hepatobiliary Cancers in Saudi Arabia From 2000 to 2025
Khalil I Alshammari, Ibrahim Ginawi, Hisham Sherfi, Hussain G Ahmed
Cureus.2025;[Epub] CrossRef Drug-loaded indocyanine green J-aggregates activate metalloimmunotherapy for sustained photothermal therapy of hepatocellular carcinoma
Kaiming He, Desheng Chen, Dongzi Zhu, Wenjie Zheng, Lei Lyu, Mingshen Zhang, Zeping Chen, Xiaowen Wang, Yongwei Hu, Binsheng Fu
Journal of Nanobiotechnology.2025;[Epub] CrossRef Application of LI-RADS CT/MRI Radiation Treatment Response Assessment Version 2024: a study after transarterial radioembolization for hepatocellular carcinoma
Jaeseung Shin, Sunyoung Lee, Ja Kyung Yoon, Kyowon Gu, Sun-Young Baek, Dong-Ho Hyun, Gyoung Min Kim, Jong Yun Won
Japanese Journal of Radiology.2025;[Epub] CrossRef METTL1-driven nucleotide metabolism reprograms the immune microenvironment in hepatocellular carcinoma: a multi-omics approach for prognostic biomarker discovery
Xie Weng, Yangyue Huang, Zhuoya Fu, Xingli Liu, Fuli Xie, Jiale Wang, Qiaohua Zhu, Dayong Zheng
Frontiers in Immunology.2025;[Epub] CrossRef Targeting PCNA/PARP1 axis inhibits the malignant progression of hepatocellular carcinoma
Jipin Li, Tao Yong, Yali Chen, Tingyu Zeng, Kaifeng Zhang, Shuping Wang, Youcheng Zhang
Frontiers in Pharmacology.2025;[Epub] CrossRef B cell receptor repertoire signature as a diagnostic biomarker for hepatocellular carcinoma
Zixue Xuan, Qiang Ye, Guobing Zhang, Xin Zhang
Asian Journal of Surgery.2025;[Epub] CrossRef Systemic Chemotherapy with Combination of Immune Checkpoint Inhibitor and Tyrosine Kinase Inhibitor in Unresectable Hepatocellular Carcinoma
Hye Yeon Chon
The Korean Journal of Gastroenterology.2024; 83(2): 78. CrossRef An integrated investigation of sulfotransferases (SULTs) in hepatocellular carcinoma and identification of the role of SULT2A1 on stemness
Hao Peng, Kun Feng, Weilu Jia, Yunxin Li, Qingpeng Lv, Yewei Zhang
Apoptosis.2024; 29(5-6): 898. CrossRef Exploring the prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma
Ji Eun Han, Hyo Jung Cho
Clinical and Molecular Hepatology.2024; 30(2): 160. CrossRef Comparison between Nivolumab and Regorafenib as Second-line Systemic Therapies after Sorafenib Failure in Patients with Hepatocellular Carcinoma
Hong Jun Lee, Jae Seung Lee, Hyesung So, Ja Kyung Yoon, Jin-Young Choi, Hye Won Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Do Young Kim
Yonsei Medical Journal.2024; 65(7): 371. CrossRef Immune signature and therapeutic approach of natural killer cell in chronic liver disease and hepatocellular carcinoma
Seung Kak Shin, Sooyeon Oh, Su‐Kyung Chun, Min‐Ji Ahn, Seung‐Min Lee, Kayun Kim, Hogyeong Kang, Jeongwoo Lee, Suk Pyo Shin, Jooho Lee, Young Kul Jung
Journal of Gastroenterology and Hepatology.2024; 39(9): 1717. CrossRef Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma
Jiwon Hong, Jung Woo Eun, Geum Ok Baek, Jae Youn Cheong, Seryoung Park, Soon Sun Kim, Hyo Jung Cho, Su Bin Lim
Clinical and Molecular Hepatology.2024; 30(3): 360. CrossRef Inflammatory Response in the Pathogenesis and Treatment of Hepatocellular Carcinoma: A Double-Edged Weapon
Linda Galasso, Lucia Cerrito, Valeria Maccauro, Fabrizio Termite, Irene Mignini, Giorgio Esposto, Raffaele Borriello, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco
International Journal of Molecular Sciences.2024; 25(13): 7191. CrossRef Limited Generalizability of Retrospective Single-Center Cohort Study in Comparison to Multicenter Cohort Study on Prognosis of Hepatocellular Carcinoma
Ye Rim Kim, Sung Won Chung, Min-Ju Kim, Won-Mook Choi, Jonggi Choi, Danbi Lee, Han Chu Lee, Ju Hyun Shim
Journal of Hepatocellular Carcinoma.2024; Volume 11: 1235. CrossRef Does rAj-Tspin, a novel peptide from A. japonicus, exert antihepatocellular carcinoma effects via the ITGB1/ZYX/FAK/AKT signaling pathway?
Ying Che, Xiaolong Lu, Xueting Wang, Zhien Liu, Liyang Guan, Xin Li, Zaixing Du, Hang Ren, Jihong Wang, Zunchun Zhou, Li Lv
Cancer Cell International.2024;[Epub] CrossRef Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity
Mi Na Kim, Beom Kyung Kim, Heejin Cho, Myung Ji Goh, Yun Ho Roh, Su Jong Yu, Dong Hyun Sinn, Soo Young Park, Seung Up Kim, Tyng-Yuan Jang
PLOS ONE.2024; 19(8): e0307712. CrossRef
Calculus bovis in hepatocellular carcinoma: Tumor molecular basis, Wnt/β-catenin pathway role, and protective mechanism
Khaled Mohamed Mohamed Koriem
World Journal of Gastroenterology.2024; 30(35): 3959. CrossRef Role of transarterial chemoembolization for hepatocellular carcinoma with extrahepatic metastases in the era of advancing systemic therapy
Byeong Geun Song, Myung Ji Goh, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Moon Seok Choi
Journal of Liver Cancer.2024; 24(2): 243. CrossRef Preoperative C-reactive protein to albumin ratio may be a good prognostic marker in patients undergoing hepatectomy for hepatocellular carcinoma: a meta-analysis
Shi Wang, Shengqian Xu, Jun Wang, Hailin Ye, Kai Zhang, Xiaopeng Fan, Xiaoya Xu
Frontiers in Nutrition.2024;[Epub] CrossRef Dynamic Peripheral T-Cell Analysis Identifies On-Treatment Prognostic Biomarkers of Atezolizumab plus Bevacizumab in Hepatocellular Carcinoma
Ji Won Han, Min Woo Kang, Soon Kyu Lee, Hyun Yang, Ji Hoon Kim, Jae-Sung Yoo, Hee Sun Cho, Eun Ji Jang, Deok Hwa Seo, Jung Hyun Kwon, Soon Woo Nam, Si Hyun Bae, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Pil Soo Sung
Liver Cancer.2024; : 1. CrossRef Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial
Sun Young Yim, Sung Hwan Lee, Seung-Woo Baek, Bohwa Sohn, Yun Seong Jeong, Sang-Hee Kang, Kena Park, Hyewon Park, Sunyoung S. Lee, Ahmed O. Kaseb, Young Nyun Park, Sun-Hee Leem, Michael A. Curran, Ji Hoon Kim, Ju-Seog Lee
Clinical and Molecular Hepatology.2024; 30(4): 807. CrossRef CAF-derived miR-642a-3p supports migration, invasion, and EMT of hepatocellular carcinoma cells by targeting SERPINE1
Shuo Zhang, Gang Cao, Shuijie Shen, Yu Wu, Xiying Tan, Xiaoyan Jiang
PeerJ.2024; 12: e18428. CrossRef A pan-cancer analysis of the oncogenic function of HMGB1 in human tumors
Hui-min Yang, Xiang-ning Zhao, Xiao-ling Li, Xi Wang, Yu Pu, Dong-kai Wei, Zhe Li
Biochemistry and Biophysics Reports.2024; 40: 101851. CrossRef Hypoxia upregulates hepatic angiopoietin-2 transcription to promote the progression of hepatocellular carcinoma
Jun-Ling Yang, Jie Yang, Rong-Fei Fang, Wen-Li Sai, Deng-Fu Yao, Min Yao
World Journal of Hepatology.2024; 16(12): 1480. CrossRef Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab
Jaejun Lee, Jae-Sung Yoo, Ji Hoon Kim, Dong Yeup Lee, Keungmo Yang, Bohyun Kim, Joon-Il Choi, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Ji Won Han, Pil Soo Sung
Frontiers in Immunology.2024;[Epub] CrossRef CMTM6 promotes hepatocellular carcinoma invasion and metastasis and tumor-associated neutrophil immunoinfiltration through the Wnt/β-catenin pathway
Panpan Kong, Huan Yang, Huifang Liu, Qing Tong, Mamumaimaitijiang-Abula Yi, Yong Zhao, Dong Yan
European Journal of Medical Research.2024;[Epub] CrossRef
|